Skip to content

NIH Symposium: Challenges & Promise of Cell-Based Therapies

Webcast of Symposium

(RealOne Player is required to view the webcast.)

Challenges & Promise of Cell-Based Therapies
Tuesday, May 06, 2008
Author/Sponsor: The National Institutes of Health
Total Running Time: 06:05:06
Bandwidth: 33 Kbps
This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.


May 6, 2008
Natcher Conference Center
NIH Main Campus, Bethesda, Maryland

Planning Committee

Agenda

7:30–8:00 a.m. Registration
8:00–8:05 a.m. Welcome/Opening Remarks
Story C. Landis, Ph.D., National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH)
Summary
8:10–8:40 a.m. Overview of Current Hematopoietic Stem Cell Therapy
Stuart H. Orkin, M.D., Dana Farber Cancer Institute, Harvard Medical School, and Howard Hughes Medical Institute
Abstract | Summary
Session 1: Neurological Disorders
8:40–10:20 a.m. Moderator: Ronald McKay, Ph.D., National Institute of Neurological Disorders and Stroke, NIH

Bone Marrow-Derived Stem Cells and Multiple Sclerosis
Mark S. Freedman, M.D., M.Sc., Ottawa Health Research Institute and University of Ottawa
Abstract | Summary

Combining Stem Cell and Gene Therapy for Neurological Disorders
Clive N. Svendsen, Ph.D., University of Wisconsin-Madison
Abstract | Summary

Preclinical Development of Remyelination and Motor Neuron Replacement Strategies in the Central Nervous System
Douglas Kerr, M.D., Ph.D., Transverse Myelitis Center, Johns Hopkins University
Abstract | Summary

10:20–10:35 a.m. Break
Session 2: Cardiac Disorders
10:45–12:15 p.m. Moderator: Sonia Skarlatos, Ph.D., National Heart, Lung, and Blood Institute, NIH

Clinical Trials on Cell-Based Therapies for Cardiac Repair
Douglas W. Losordo, M.D., Northwestern University
Abstract | Summary

Cardiac Niches and Control of Progenitor Cell Differentiation
Annarosa Leri, M.D., Harvard Medical School
Abstract | Summary

Human Embryonic Stem Cells for Cardiac Tissue Engineering
Michael A. Laflamme, M.D., Ph.D., University of Washington
Abstract | Summary

12:15 p.m.–1:15 p.m. Lunch (Natcher Conference Center)
Lunch on your own
Session 3: Musculoskeletal Disorders
1:15 p.m.–2:55 p.m

Moderator: Pamela Robey, Ph.D., National Institute of Dental and Craniofacial Research, NIH

Stem Cells and Muscular Dystrophy
Terence A. Partridge, Ph.D., Children's National Medical Center
Abstract | Summary

Repair of Bone and Other Tissues by the Adult Stem/Progenitor Cells From Bone Marrow Referred to as Mesenchymal Stem Cells or Multipotent Mesenchymal Stromal Cells
Darwin Prockop, M.D., Ph.D., Tulane University Medical School
Abstract | Summary

Tackling Crippling Diseases in Bone and Other Mesoderm Derivatives Through Postnatal Progenitors
Paolo Bianco, M.D., Sapienza—Universita' di Roma
Abstract | Summary

2:55–3:10 p.m. Break
Session 4: Metabolic Disorders
3:10–4:50 p.m.

Moderator: James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, NIH

Principles for Guiding Stem Cells to Liver and Pancreas Fates
Kenneth Zaret, Ph.D., Fox Chase Cancer Center
Abstract | Summary

Challenges to Clinical Cell-Based Liver Therapy
Markus Grompe, M.D., Oregon Health & Science University
Abstract | Summary

Engineering Approaches in Controlling Cell Behavior and Designing Cell-Based Therapies
Linda Griffith, Ph.D., Massachussetts Institute of Technology
Abstract | Summary

4:50–5:20 p.m. Patient-Specific Pluripotent Stem Cells
George Daley, M.D., Ph.D., Harvard Stem Cell Institute
Abstract | Summary
5:20–5:30 p.m. Closing Remarks and Summary
James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, NIH
Summary
5:30 p.m. Adjournment